Cipher Pharmaceuticals

Cipher Pharmaceuticals is a specialty pharmaceutical company that develops and acquires innovative skin care solutions to address unmet medical needs. The company offers a range of prescription dermatology products, including Bionect for managing various skin injuries and Nuvail for nail dystrophy. Additionally, it provides consumer skin care products such as AL12, Inova, Pro: 12 Mousse, and Umecta, which target moisture retention and skin repair. Cipher also markets prescription medications like Absorica for severe acne and ConZip for chronic pain management. The company focuses on enhancing existing drug formulations through novel delivery technologies and actively seeks to in-license products to expand its portfolio. Cipher Pharmaceuticals operates primarily in Canada and the United States and has been part of EPI Health, LLC since 2017.